Loading stock data...

Deccan Health Care Limited

BSE: DECCAN

BSE
15.40 0.24 (1.58%)

Prev Close

15.16

Open Price

15.5

Volume

4,507

Today Low / High

14.75 / 15.5

52 WK Low / High

13 / 31.6

Range

15 - 16

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 15.4, reflecting a change of 0.24 (1.58311%). The expected target range on the BSE is 15 - 16. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

05 Jan 15.50 -0.65%
02 Jan 15.15 0.07%
01 Jan 15.45 -2.91%
31 Dec 15.15 -2.24%
30 Dec 14.33 2.65%
29 Dec 14.90 -1.54%
26 Dec 15.90 -4.09%
24 Dec 15.84 -2.46%
23 Dec 15.64 -3.45%
22 Dec 16.19 -6.61%
19 Dec 15.90 -1.07%
18 Dec 16.40 -3.05%
17 Dec 15.37 2.67%
16 Dec 16.30 -2.15%
15 Dec 16.80 -5.18%
12 Dec 15.22 6.83%
11 Dec 15.79 -5.07%
10 Dec 15.44 -0.39%
09 Dec 14.95 -1.14%
08 Dec 15.02 -3.00%

Deccan Health Care Limited Graph

Deccan Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Deccan Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 15.40, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 15.40 15.55 14.00 - 17.11
15.71 12.57 - 18.85
15.86 11.10 - 20.62
Bearish Scenario 15.40 15.25 13.72 - 16.77
15.09 12.07 - 18.11
14.94 10.46 - 19.42

Overview of Deccan Health Care Limited

ISIN

INE452W01019

Industry

Medical - Pharmaceuticals

Vol.Avg

30,054

Market Cap

360,406,031

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

36.38

DCF

-14

Financial Ratios Every Investor Needs

Stock Rating Details for DECCAN

Metric Value Recommendation
Overall Rating B Neutral
DCF Score 1 Strong Sell
ROE Score 2 Sell
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 5 Strong Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 75.06 Cr 47.50 Cr 27.56 Cr 0.3672 0.00 Cr 2.14 Cr 1.70 Cr 1.16 Cr 0.56 3.16 Cr 0.0154
2024-03-31 59.73 Cr 40.70 Cr 19.03 Cr 0.3187 0.00 Cr 2.57 Cr 2.29 Cr 1.49 Cr 0.80 3.75 Cr 0.0250
2023-03-31 45.02 Cr 31.77 Cr 13.26 Cr 0.2944 0.01 Cr 1.27 Cr 0.61 Cr 0.31 Cr 0.24 1.98 Cr 0.0068
2022-03-31 33.17 Cr 19.98 Cr 13.20 Cr 0.3978 0.01 Cr 0.72 Cr 4.16 Cr 0.32 Cr 0.21 2.13 Cr 0.0097
2021-03-31 33.78 Cr 24.12 Cr 9.66 Cr 0.2859 0.05 Cr 0.58 Cr 12.12 Cr 0.39 Cr 0.25 2.06 Cr 0.0115

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 4.46 Cr 124.93 Cr 18.54 Cr 106.3907 Cr 1.15 Cr -3.31 Cr 42.60 Cr 14.37 Cr 0.00 Cr 0.00 Cr 0.14 Cr 15.6970 Cr
2024-03-31 2.60 Cr 108.05 Cr 11.13 Cr 96.9144 Cr 1.90 Cr -0.71 Cr 45.70 Cr 15.68 Cr 0.00 Cr 0.00 Cr 0.02 Cr 7.4959 Cr
2023-03-31 1.41 Cr 96.78 Cr 15.22 Cr 81.5619 Cr 1.62 Cr 0.21 Cr 62.09 Cr 16.83 Cr 0.00 Cr 0.00 Cr 0.02 Cr 11.7486 Cr
2022-03-31 2.67 Cr 90.63 Cr 13.68 Cr 76.9447 Cr 1.25 Cr -1.42 Cr 46.50 Cr 18.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr 10.4886 Cr
2021-03-31 3.21 Cr 92.27 Cr 15.65 Cr 76.6221 Cr 1.03 Cr -2.18 Cr 50.74 Cr 19.87 Cr 0.00 Cr 0.00 Cr 0.00 Cr 12.7117 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -6.4274 Cr -0.1367 Cr 7.5153 Cr -6.5698 Cr 0.9512 Cr 3.5539 Cr -0.1424 Cr 1.6302 Cr -0.7496 Cr 0.0000 Cr 3.0922 Cr
2024-03-31 -12.5514 Cr -0.2998 Cr 14.0439 Cr -12.8624 Cr 1.1927 Cr 2.6027 Cr -0.3110 Cr 1.4926 Cr 0.2776 Cr 0.0000 Cr 1.0568 Cr
2023-03-31 -6.7647 Cr 0.2703 Cr 5.2605 Cr -6.7647 Cr -1.2575 Cr 1.4100 Cr 0.0000 Cr 0.4397 Cr 0.3863 Cr 0.0000 Cr -0.2502 Cr
2022-03-31 -0.5730 Cr -0.0494 Cr 0.0673 Cr -0.6850 Cr -0.5551 Cr 2.6675 Cr -0.1120 Cr 0.3226 Cr 0.2191 Cr 0.0000 Cr -1.5237 Cr
2021-03-31 0.2193 Cr -0.0817 Cr -0.2624 Cr 0.0609 Cr -0.2227 Cr 3.2226 Cr -0.1584 Cr 0.3899 Cr -0.2624 Cr 0.0000 Cr -7.0790 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 21.40 Cr 14.46 Cr 6.94 Cr 0.3243 1.39 Cr 0.91 Cr 0.37 1.72 Cr 0.0427
2025-06-30 22.14 Cr 15.50 Cr 6.64 Cr 0.2998 0.34 Cr 0.24 Cr 0.10 0.76 Cr 0.0107
2025-03-31 20.75 Cr 14.02 Cr 6.73 Cr 0.3242 0.25 Cr 0.12 Cr 0.06 0.61 Cr 0.0060
2024-12-31 20.43 Cr 13.36 Cr 7.07 Cr 0.3460 0.22 Cr 0.14 Cr 0.07 0.58 Cr 0.0071
2024-09-30 18.82 Cr 11.36 Cr 7.46 Cr 0.3962 0.73 Cr 0.53 Cr 0.26 1.10 Cr 0.0281

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 1.89 Cr 0.02 Cr 1.89 Cr 14.64 Cr 45.92 Cr 120.41 Cr 13.68 Cr 138.27 Cr 29.44 Cr
2025-06-30 0.00 Cr 0.00 Cr 3.55 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -106.39 Cr
2025-03-31 3.55 Cr 0.91 Cr 4.46 Cr 12.54 Cr 42.60 Cr 106.24 Cr 14.37 Cr 124.93 Cr 18.54 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.96 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -99.16 Cr
2024-09-30 1.96 Cr 0.84 Cr 2.80 Cr 10.04 Cr 44.24 Cr 93.66 Cr 15.02 Cr 113.18 Cr 14.02 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.53 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹832.50 ₹99,706,606,920.00 ₹80,828.00

Key Executives

Chief of Production
Siddharth Pandey

Gender: Not Specified

Year Born:

Chief Operating Officer of IT & D2C
Arun Srivastava

Gender: male

Year Born:

Chief Operating Officer of OTC & D2R
Gurinder Singh

Gender: male

Year Born:

Chief Operating Officer of Unit-1 Operations & D2B
Jitendra Upadhya

Gender: male

Year Born:

Chief Operating Officer of RO Co-ordination Filing Control
Srinivas

Gender: male

Year Born:

Chief Commercial Officer & Whole Time Executive Director
Mohak Gupta

Gender: male

Year Born:

Chief of Corporate Affairs
Rani Venkata Satya Umamaheswara Rao

Gender: male

Year Born: 1966

Company Secretary & Compliance Officer
Ronak Rajeshbhai Darji

Gender: male

Year Born:

COO & Compliance Officer
Mohita Gupta

Gender: female

Year Born: 1990

Chief Financial Officer
Parth H. Palera

Gender: female

Year Born:

Founder, Executive Chairman & MD
Minto Purshotam Gupta

Gender: Not Specified

Year Born: 1958

FAQs about Deccan Health Care Limited

Who is the CEO of the company?

The CEO is Minto Purshotam Gupta.

What is the current market price of the stock?

The current price is ₹15.40.

What is the 52-week price range?

The range is ₹13-31.6.

What is the market capitalization of the company?

The market capitalization is ₹36.04 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 26.81.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Deccan Health Care Limited (ISIN: INE452W01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹36.04 crores and an average daily volume of 30,054 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.